1. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. I. Biochemical profile;Curet;J. Pharmacol. Exp. Ther.,1996
2. Preclinical profile of befloxatone, a new reversible MAO-A inhibitor;Curet;J. Affect. Disord.,1998
3. Do smokers self-administer pure nicotine? A review of the evidence;Dar;Psychopharmacology,2004
4. Dopamine in schizophrenia: a review and reconceptualization;Davis;Am. J. Psychiatry,1991
5. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons;Engberg;J. Pharmacol. Exp. Ther.,1991